Aflac AFL Cancer — Gross premiums
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Aflac in its filing.
Tagged under the XBRL concept us-gaap:LiabilityForFuturePolicyBenefitExpectedFutureGrossPremiumDiscountedBeforeReinsurance.
The official record: Aflac’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Aflac's cancer — gross premiums.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Aflac's cancer — gross premiums?
- Aflac (AFL) reported cancer — gross premiums of $34.77B in Q1 2026.
- How has Aflac's cancer — gross premiums changed year-over-year?
- Aflac's cancer — gross premiums increased by 4043.9% year-over-year, from $839M to $34.77B.
- What is the long-term trend for Aflac's cancer — gross premiums?
- Over 3 years (2021 to 2025), Aflac's cancer — gross premiums has grown at a 174.7% compound annual growth rate (CAGR), from $5.73B to $118.78B.
- What does cancer — gross premiums mean?
- The total amount of money collected from cancer insurance customers before accounting for reinsurance costs.
- How do you interpret cancer — gross premiums?
- Growth in gross premiums indicates successful sales and market penetration in the cancer insurance category.
- How does cancer — gross premiums compare across companies?
- Standard top-line revenue metric for insurance segments across the industry.